Cornelis P. de Joncheere
Born in 1954. National of the Kingdom of the Netherlands. Currently Chair of the Netherlands Antibiotics Development Platform and a consultant to WHO on pharmaceutical policies.
Doctor of Pharmacy (PharmD) and Master of Science (MSc) in Pharmacy, University of Groningen and University of Amsterdam, Kingdom of the Netherlands (1975-1981); Master's in Business Administration, University of San Diego, United States/San José, Costa Rica; Bachelor of Science (BSc). Pharmacy, cum laude (honour student), University of Groningen, Kingdom of the Netherlands (1972-1975).
Previously held positions as Director, Department of Essential Medicines and Health Products at WHO, Geneva (2012-2016), which included work on access to controlled medicines, and the WHO Expert Committee on Drug Dependence; WHO Representative, Kyiv (2011-2012); WHO Regional Adviser for Pharmaceuticals and Health Technologies, WHO Regional Office for Europe, Copenhagen (1996-2010); National Essential Drugs Programme Coordinator, Pan American Health Organization (PAHO)/WHO, Brazil (1994-1996); Pharmacist, Essential Drugs Projects Coordinator, PAHO/WHO, Costa Rica (1988-1993); Pharmaceutical expert, PAHO/WHO, Panama (1986-1988); pharmaceutical supply expert in North Yemen, Ministry of Foreign Affairs, Directorate for International Cooperation, Kingdom of the Netherlands (1982-1985); hospital and community pharmacy in Amsterdam (1981-1982).
President of the WHO Europe Staff Association (2006-2010); member of the WHO Guidelines Review Committee (2007-2011); member of the Royal Dutch Pharmaceutical Society; author and co-author of numerous publications in the fields of pharmaceutical and health sciences.
Member of the International Narcotics Control Board (since 2017) [1]. Rapporteur (2017, 2023 and 2025). Member of the Standing Committee on Estimates (2017-2018, 2021-2022 and 2024-2025). Member (2017-2018 and 2021) and Chair (2022 and 2024) of the Committee on Finance and Administration. President of the Board (2019-2020).
[1] Elected by the Economic and Social Council on 5 April 2016; re-elected by the Council for a five-year term (2022-2027) on 20 April 2021.